PRGs showed a high sensitivity to mutation, with APOC1, NCAPG, FXYD1, and F2R mainly exhibiting heterozygous deletion in GBM, whereas PDE2A, BMP2, IFI30, and PTBP1 exhibited heterozygous amplification as the main CNV type. The gene discussed is IFI30; the disease is glioblastoma.